| 11839689 |
Formulations of enzalutamide |
Sanjay Konagurthu, Randy J. Wald, Jason A. Everett, Sheila Matz, Yuuki Takaishi +6 more |
2023-12-12 |
| 10398713 |
Compositions and methods for the treatment of neurodegenerative and other diseases |
Thaddeus Cromwell Reeder, Mark Wade Moore, David Keith Lyon |
2019-09-03 |
| 10098843 |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
Charles A. McWherter, Robert Martin, David Karpf, Brian K. Roberts, Rodney James Ketner |
2018-10-16 |
| 9980978 |
Compositions and methods for the treatment of neurodegenerative and other diseases |
Thaddeus Cromwell Reeder, Mark Wade Moore, David Keith Lyon |
2018-05-29 |
| 9974798 |
Compositions and methods for the treatment of neurodegenerative and other diseases |
Thaddeus Cromwell Reeder, Mark Wade Moore, David Keith Lyon |
2018-05-22 |
| 9918997 |
Compositions and methods for the treatment of neurodegenerative and other diseases |
Thaddeus Cromwell Reeder, Mark Wade Moore, David Keith Lyon |
2018-03-20 |
| 9597339 |
Compositions and methods for the treatment of neurodegenerative and other diseases |
Thaddeus Cromwell Reeder, Mark Wade Moore, David Keith Lyon |
2017-03-21 |
| 9468604 |
Pharmaceutical compositions of dispersions of drug and neutral polymers |
Dwayne T. Friesen, Michael Gumkowski, Rodney James Ketner, James A. S. Nightingale, Ravi M. Shanker +1 more |
2016-10-18 |
| 9457095 |
Pharmaceutical compositions providing enhanced drug concentrations |
William J. Curatolo, Ravi M. Shanker, Walter C. Babcock, Dwayne T. Friesen, James A. S. Nightingale |
2016-10-04 |
| 9241924 |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
Charles A. McWherter, Robert Martin, David Karpf, Brian K. Roberts, Rodney James Ketner |
2016-01-26 |
| 8980321 |
Pharmaceutical compositions providing enhanced drug concentrations |
William J. Curatolo, Ravi M. Shanker, Walter C. Babcock, Dwayne T. Friesen, James A. S. Nightingale |
2015-03-17 |
| 8796341 |
Pharmaceutical compositions providing enhanced drug concentrations |
William J. Curatolo, Ravi M. Shanker, Walter C. Babcock, Dwayne T. Friesen, James A. S. Nightingale |
2014-08-05 |
| 8501231 |
Pharmaceutical compositions providing enhanced drug concentrations |
William J. Curatolo, Ravi M. Shanker, Walter C. Babcock, Dwayne T. Friesen, James A. S. Nightingale |
2013-08-06 |
| 8389011 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
Marshall Crew, William J. Curatolo, Dwayne T. Friesen, Michael Gumkowski, James A. S. Nightingale +2 more |
2013-03-05 |
| 8372836 |
Spray dried formulation |
Rodney James Ketner, David Keith Lyon |
2013-02-12 |
| 8202912 |
Pharmaceutical compositions providing enhanced drug concentrations |
William J. Curatolo, Ravi M. Shanker, Walter C. Babcock, Dwayne T. Friesen, James A. S. Nightingale |
2012-06-19 |
| 8197848 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
Marshall Crew, William J. Curatolo, Dwayne T. Friesen, Michael Gumkowski, James A. S. Nightingale +2 more |
2012-06-12 |
| 8048452 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor |
William J. Curatolo, Dwayne T. Friesen, Michael Gumkowski, James A. S. Nightingale, Roger B. Ruggeri +1 more |
2011-11-01 |
| 8026286 |
Pharmaceutical compositions providing enhanced drug concentrations |
William J. Curatolo, Ravi M. Shanker, Walter C. Babcock, Dwayne T. Friesen, James A. S. Nightingale |
2011-09-27 |
| 7897175 |
Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor |
Dwayne T. Friesen, David Keith Lyon, Bruno Hancock, Timothy J. McDermott, Ravi M. Shanker |
2011-03-01 |
| 7655692 |
Process for forming amorphous atorvastatin |
Kenneth C. Waterman |
2010-02-02 |
| 7235259 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
Marshall Crew, William J. Curatolo, Dwayne T. Friesen, Michael Gumkowski, James A. S. Nightingale +2 more |
2007-06-26 |
| 7115279 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
William J. Curatolo, Dwayne T. Friesen, Michael Gumkowski, James Nightingale, Roger B. Ruggeri +1 more |
2006-10-03 |
| 5288916 |
Enantiomeric resolution of 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone |
Daniel J. Brose |
1994-02-22 |
